Skip to main content

Table 1 Preoperative recipient findings in the non-infected and infected groups

From: Risk stratification for early bacteremia after living donor liver transplantation: a retrospective observational cohort study

Group

Non-infection

Infection

p

n

539

57

 

Age (years)

53 (48–59)

54 (46–62)

0.845

Sex (male)

378 (70.1%)

41 (71.9%)

0.777

Body mass index (kg·m-2)

24.2 (22.1–26.6)

23.8 (21.3–25.7)

0.181

Psoas muscle index (mm2·m-2)

329.7 (261.0–401.4)

295.7 (226.8–370.9)

0.014

Etiology

  

0.543

 Alcohol use

127 (23.6%)

10 (17.5%)

 

 Hepatitis A

21 (3.9%)

4 (7.0%)

 

 Hepatitis B

292 (54.2%)

29 (50.9%)

 

 Hepatitis C

33 (6.1%)

6 (10.5%)

 

 Autoimmune disorder

23 (4.3%)

4 (7.0%)

 

 Drugs and toxins

14 (2.6%)

2 (3.5%)

 

 Cryptogenic

29 (5.4%)

2 (3.5%)

 

Comorbidity

 Diabetes mellitus

143 (26.5%)

12 (21.1%)

0.370

 Hypertension

107 (19.9%)

11 (19.3%)

0.921

MELD score (points)

15 (9–26)

22 (13–35)

0.001

CRRT

67 (12.4%)

15 (26.3%)

0.004

Hepatocellular carcinoma

240 (44.5%)

19 (33.3%)

0.105

 Beyond the Milan criteria

24 (22.0%)

1 (16.7%)

1.000

Hepatic decompensation

 Encephalopathy

50 (9.3%)

5 (8.8%)

0.900

 Varix

132 (24.5%)

12 (21.1%)

0.564

 Ascites

248 (46.0%)

33 (57.9%)

0.087

Cardiac function

 Ejection fraction (%)

64.6 (62.0–67.0)

64.6 (63.5–67.0)

0.174

 Diastolic dysfunction

230 (42.7%)

25 (43.9%)

0.863

Laboratory variables

 Hemoglobin (g·dL-1)

9.8 (8.4–11.6)

9.2 (8.1–11.1)

0.243

 WBC count (×109·L-1)

4.4 (2.8–7.3)

4.4 (2.7–9.6)

0.689

 C-reactive protein to albumin ratio

0.14 (0.04–0.54)

0.25 (0.07–0.88)

0.003

  C-reactive protein (mg·dL-1)

0.4 (0.1–1.5)

0.8 (0.2–2.3)

0.005

  Albumin (g·dL-1)

3.0 (2.6–3.4)

2.8 (2.6–3.4)

0.058

 Neutrophil to lymphocyte ratio

2.80 (1.67–6.03)

3.99 (2.31–10.28)

0.002

  Neutrophils (×109·L-1)

2.5 (1.5–5.0)

2.8 (1.7–6.8)

0.131

  Lymphocytes (×109·L-1)

0.9 (0.6–1.4)

0.8 (0.4–1.2)

0.031

 Platelet to lymphocyte ratio

76.09 (53.09–112.09)

81.27 (54.22–115.38)

0.583

  Platelet count (×109·L-1)

63.0 (45.0–102.0)

57.0 (37.5–86.0)

0.060

 Sodium (mEq·L-1)

139 (135–142)

138 (134–141)

0.117

 Potassium (mEq·L-1)

4.0 (3.7–4.3)

3.9 (3.6–4.5)

0.832

 Total bilirubin (mg·dL-1)

2.5 (0.9–13.4)

2.8 (0.9–28.6)

0.204

 International normalized ratio

1.5 (1.2–2.1)

1.5 (1.3–2.0)

0.777

 Creatinine (mg·dL-1)

0.8 (0.7–1.2)

1.0 (0.7–2.0)

0.025

 Glucose (mg·dL-1)

109 (92 –139)

113 (95–143)

0.555

  1. Abbreviations: CRRT Continuous renal replacement therapy, MELD Model for end-stage liver disease, WBC White blood cell
  2. NOTE: Values are medians (interquartile range) or numbers (%)